Phenomix Sciences (Series A)
Funding Details
Awarder
Inbox
Date Award
May 16, 2024
Vertical
Biotechnology
Funding Amount
$5,500,000
Company Info
Founders
Andres Acosta, M.D. Ph.D., Michael Camilleri, M.D. D.Sc.
Market
Obesity Treatment
Location
Wayzata, Minnesota, USA
Coinvestors
Dexcom Ventures, Health 2047 Capital Partners, LabCorp
Company Description

Phenomix Sciences is a precision obesity biotechnology company on a mission to conquer obesity globally through the use of our proprietary genetic tests, unique data sets, and advanced analytics. The company leverages data intelligence for yielding better accuracy in predicting individual patient response to specific weight loss interventions.

Links